CoChat

Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial

Open access
Huang, Susan S, Septimus, Edward, Kleinman, Ken, Moody, Julia, Hickok, Jason, Heim, Lauren, Gombosev, Adrijana, Avery, Taliser R, Haffenreffer, Katherine, Shimelman, Lauren, Hayden, Mary K, Weinstein, Robert A, Spencer-Smith, Caren, Kaganov, Rebecca E, Murphy, Michael V, Forehand, Tyler, Lankiewicz, Julie, Coady, Micaela H, Portillo, Lena, Sarup-Patel, Jalpa, Jernigan, John A, Perlin, Jonathan B, Platt, Richard · 2019 · The Lancet
Cited by 143

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Structured Summary Background: Universal skin and nasal decolonization reduces multidrug-resistant pathogens and bloodstream infections in intensive care units. The effect of universal decolonization on pathogens and infections in non-critical care units is unknown. Methods: A two-arm cluster-randomized trial was conducted in 53 hospitals in the Hospital Corporation of America Healthcare system. Hospitals were randomized and their participating non-critical care units assigned to either routine care or daily Chlorhexidine bathing for all patients plus mupirocin for known methicillin-resistant Staphylococcus aureus (MRSA) carriers. The trial involved a 12-month baseline (Mar 2013-Feb 2014) and 21-month intervention (Jun 2014-Feb 2016). Primary outcome was MRSA or vancomycin-resistant enterococcus (VRE) clinical cultures attributed to participating units, and secondary outcome was all-pathogen bloodstream infection. Proportional hazards models assessed differences in outcome reductions across arms, accounting for clustering by hospital. Findings: There were 189,081 patients in the baseline period and 339,902 patients (156,889 patients in the routine care group and 183,013 patients in the decolonization group) in the intervention period across 194 non-critical care units in 53 hospitals. Hazard ratios for MRSAA/RE clinical isolates during intervention vs. baseline periods were 0·87 (CI:0·79, 0·95) for routine care, and 0·79 (CI:0·73, 0·87) for decolonization (ρ=0·17), and 0·96 (CI:0·85, 1·08) and 0·90 (0·81, 1·01) for all-pathogen bloodstream infection, respectively (p=0·44). Adverse events were rare (1 in >7,000; 25/183,013) for Chlorhexidine and none were reported for mupirocin. Interpretation: Decolonization with universal Chlorhexidine bathing and targeted mupirocin for MRSA carriers did not reduce multidrug-resistant organisms or all-pathogen bloodstream infection in all non-critical care patients. Trial Registration: clinicaltrials.gov Identifier:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(18)32593-5

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 143

Metadata

Authors
Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Heim, L., Gombosev, A., Avery, T. R., Haffenreffer, K., Shimelman, L., Hayden, M. K., Weinstein, R. A., Spencer-Smith, C., Kaganov, R. E., Murphy, M. V., Forehand, T., Lankiewicz, J., Coady, M. H., Portillo, L., Sarup-Patel, J., Jernigan, J. A., Perlin, J. B., & Platt, R.
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-03
Volume
393
Issue
10177
Pages
1205-1215
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2919817910
Cited by
143
References
4
FWCI
10.64
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. https://app.cochat.ai/papers/10.1016/s0140-6736(18)32593-5
The paper
Huang, S. S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Heim, L., Gombosev, A., Avery, T. R., Haffenreffer, K., Shimelman, L., Hayden, M. K., Weinstein, R. A., Spencer-Smith, C., Kaganov, R. E., Murphy, M. V., Forehand, T., Lankiewicz, J., Coady, M. H., Portillo, L., . . . Platt, R. (2019). Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. The Lancet. https://doi.org/10.1016/s0140-6736(18)32593-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.